Latest Patents

Patents imply intellectual property and it has a $ value that can be associated depending on the field and type of patent that is allocated. Patents also increase the enterprise value of the company and help prevent copy-cats from copying the idea without having royalt payments or licencing deals. We like it when companies get patents awarded!. To protect IP companies aggressively file provisional patents even before they have a working product. The below table provides a way to look at what has been done by companies and use this as a factor to make investment decisions.

     
Title Filing Date Publication Date Grant Date
Anti-c5 agent for treatment of dry age-related macular degeneration (amd) or … 2023-4-07 2023-9-14
Methods for treating or preventing ophthalmological conditions 2022-7-29 2022-10-12
Heterocyclic prolinamide derivatives 2022-5-06 2022-8-25
Methods for treating ophthalmological conditions 2021-10-31 2022-5-05
Carbocyclic prolinamide derivatives 2021-7-14 2021-11-11
Aav vectors for treatment of dominant retinitis pigmentosa 2021-5-21 2021-10-21
Aptamer therapeutics useful in the treatment of complement-related disorders 2021-3-12 2021-10-28
Minigene therapy 2020-5-19 2022-7-28
A method for treating or preventing idiopathic polypoidal choroidal … 2020-5-16 2021-4-19
Gene therapies for usher syndrome (ush2a) 2020-4-16 2022-6-30
Gene therapies for stargardt disease (abca4) 2020-4-16 2022-6-09
Adeno-associated viral vectors for the treatment of best disease 2019-8-30 2022-2-03
Compositions and methods for treatment of dominant retinitis pigmentosa 2019-6-03 2021-7-08
Minigene therapy 2018-4-05 2023-8-29 2023-8-29
Aliphatic prolinamide derivatives 2017-6-15 2020-8-04 2020-8-04
Methods for treating or preventing ophthalmological diseases 2016-12-20 2017-5-18
Combination therapy for treatment of ocular neovascular disorders 2016-7-07 2017-1-19
Methods for treating or preventing ophthalmological conditions 2015-8-07 2017-7-26
Combination therapy for the treatment of ocular neovascular disorders 2015-7-14 2015-8-06
Compositions Comprising an Anti-PDGF Aptamer and a VEGF Antagonist 2014-11-26 2015-7-02
Compositions Comprising an Anti-PDGF Aptamer and a VEGF Antagonist 2014-10-23 2015-6-11
Combination therapy for the treatment of ocular neovascular disorders 2012-12-06 2013-1-10
Combination treatment for ocular diseases 2010-4-27 2011-5-12
Aptamer therapeutics useful in the treatment of complement-related disorders 2006-2-14 2009-8-25 2009-8-25